학술논문
Survival Outcomes Following Discontinuation of Ipilimumab and Nivolumab for Advanced Melanoma in a Population-based Cohort
Document Type
Article
Author
Source
In Clinical Oncology December 2021 33(12):e561-e569
Subject
Language
ISSN
0936-6555